Startups

Clear Guide Medical closes $1.5 million Series A

And another $1.5 million could be on the way. The startup's biopsy imaging tools also have FDA approval.

Clear Guide Medical's SCENERGY and SuperPROBE in action.

(Image via YouTube)

A Johns Hopkins spinout has FDA approval and a Series A in hand, and is set to step up sales of its system to improve biopsy imaging.
Clear Guide Medical closed on $1.5 million in new funding, and could double that number with add-on investments in the near future. The round was led by Georgia-based Wildermuth Advisory.


The new money follows FDA approval in February for the company’s imaging product, called SCENERGY. Sold as an accessory to ultrasound machines, it includes a “SuperPROBE” that links an ultrasound’s existing probe with the Clear Guide¬†system. It helps specialists conducting biopsies to work with CT and ultrasound images at the same time. The system also has an automated registration process designed to reduce time.
Formed by a group of Johns Hopkins researchers in 2010, Clear Guide Medical currently works with several hospitals.  The startup is looking to expand sales in the U.S. and Europe.

-30-
Subscribe to our Newsletters
Technically Media
Connect with companies from the Technical.ly community
New call-to-action

Advertisement